Technology
Health
Medical

ATRION

$889.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.97 (-0.44%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ATRION and other stocks, options, ETFs, and crypto commission-free!

About

Atrion Corp. engages in the manufacture and development of products for medical applications. Its products include cardiac surgery vacuum relief valves, silicone vessel loops, inflation devices, stent deployment, fluid dispensing and products used in heart bypass surgery. Read More The company involves in the fluid delivery as well as ophthalmic and cardiovascular devices. It offers pressure relief valves and inflation systems to the aviation and marine industries. Atrion was founded in 1944 and is headquartered in Allen, TX.

Employees
570
Headquarters
Allen, Texas
Founded
1944
Market Cap
1.65B
Price-Earnings Ratio
47.08
Dividend Yield
0.69
Average Volume
8.12K
High Today
$894.84
Low Today
$891.63
Open Price
$894.84
Volume
224.00
52 Week High
$948.03
52 Week Low
$560.65

Collections

Technology
Health
Medical
Water Transportation
Aerospace
Transportation
Air Transportation
US

News

Seeking AlphaMay 21

Atrion declares $1.35 dividend

Atrion (NASDAQ:ATRI) declares $1.35/share quarterly dividend, in line with previous. Forward yield 0.6% Payable June 28; for shareholders of record June 14; ex-div June 13. See ATRI Dividend Scorecard, Yield Chart, & Dividend Growth....

15

Earnings

$0.00
$1.69
$3.38
$5.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.